ERS International Congress 2022: highlights from the Respiratory Infections Assembly

Radhika Banka; Kiarina Chichirelo-Konstantynovych; Katie L Horton; Tetyana Konstantynovych; Merete B Long; Melissa J McDonnell; Oliver W Meldrum; Mirae Park; Lidia Perea; Oksana Viltsaniuk; Holly R Keir

doi:10.1183/23120541.00628-2022

ERS International Congress 2022: highlights from the Respiratory Infections Assembly

ERJ Open Res. 2023 May 22;9(3):00628-2022. doi: 10.1183/23120541.00628-2022. eCollection 2023 May.

Authors

Affiliations

¹ P.D. Hinduja National Hospital and Medical Research Centre, Mumbai, India.
² Department of Infectious Diseases with the Course of Epidemiology, National Pirogov Memorial Medical University, Vinnytsya, Ukraine.
³ Primary Ciliary Dyskinesia Centre, NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
⁴ University of Southampton Faculty of Medicine, Academic Unit of Clinical and Experimental Medicine, Southampton, UK.
⁵ Department of Propedeutics of Internal Medicine, National Pirogov Memorial Medical University, Vinnytsya, Ukraine.
⁶ Scottish Centre for Respiratory Research, University of Dundee, Dundee, UK.
⁷ Galway University Hospitals and National University of Ireland, Galway, Ireland.
⁸ Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
⁹ Department of Respiratory Medicine, Imperial College Healthcare NHS Trust, London, UK.
¹⁰ Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

Abstract

The European Respiratory Society International Congress took place both in person, in Barcelona, Spain, and online in 2022. The congress welcomed over 19 000 attendees on this hybrid platform, bringing together exciting updates in respiratory science and medicine from around the world. In this article, Early Career Members of the Respiratory Infections Assembly (Assembly 10) summarise a selection of sessions across a broad range of topics, including presentations on bronchiectasis, nontuberculous mycobacteria, tuberculosis, cystic fibrosis and coronavirus disease 2019.